3
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Radiation Treatment of Human Tumours Following the in Vivo Synchronization of the Cell Cycle

, &
Pages 227-231 | Published online: 08 Jul 2009
 

Abstract

During its life the cell passes through a number of developmental stages, an event that is referred to as the cell cycle. In the S-phase of the cycle the DNA is duplicated. All cells of a tissue are statistically distributed over the entire cell cycle and enter into the M-phase at different times, so that we get the impression of a continuous growth of the tissue.

5-fluor-uracil (FU) inhibits DNA-synthesis reversibly, so that the cells accumulate at the beginning of the S-phase. Because of the rapid catabolism of FU the cells pass together through the cell cycle after the blockage is terminated; they will be synchronized.

X-ray beams harm the cells severely in the G2-phase. Thus a synchronized population should be injured very badly by irradiation in this phase.

With our in vivo and in vitro method we were able to demonstrate that the 3H-index of different tissues taken from 40 patients usually increased about 7 hours after FU infusion and was followed by a peak of mitotic cells 2 hours later as a proof of the synchronized population.

To test whether radiotherapy following synchronization would be successful, we used mice with a carcinoma of the skin induced by benzpyrene. The in this way treated animals showed clearly the lowest tumor growth with a prolongation of life-time compared with the other groups (controls, FU-treated, radiated and combined treated mice).

Working on the results of the animal experiments we used the synchronization method followed by radiotherapy for the treatment of carcinoma-patients who were in definitely incurable condition. In nearly all cases the treatment could be considered beneficial. Serious side effects have not been observed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.